BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12552518)

  • 1. A 66-year-old woman with progressive renal insufficiency, nephrotic syndrome, and monoclonal protein.
    Chang IJ; Cheunsuchon B; Miller FJ; Fogo AB
    Am J Kidney Dis; 2003 Feb; 41(2):508-17. PubMed ID: 12552518
    [No Abstract]   [Full Text] [Related]  

  • 2. The patient with insidious chronic renal failure and the patient with the nephrotic syndrome--two manifestations of a protean and not so rare disease.
    Pozzi C; Locatelli F
    Nephrol Dial Transplant; 1996 Sep; 11(9):1876-80. PubMed ID: 8918647
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-amyloid nephrotic syndrome: first isolated manifestation of a kappa light chain myeloma (author's transl)].
    Mignon F; Vasmant D; Richet G; Wang A; Morel-Maroger L; Brouet JC
    Ann Med Interne (Paris); 1979; 130(11):513-6. PubMed ID: 121516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic and renal deposits of kappa light chains revealing a dysglobulinemia (author's transl)].
    Mignon F; Morel-Maroger L; Cerf M; Preud'homme JL; Richet G
    Nephrologie; 1980; 1(4):167-70. PubMed ID: 6795518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome in a 52-year-old woman with monoclonal gammopathy.
    Levitan D; Boylen TC; Kamil ES; Koss MN
    Am J Nephrol; 1981; 1(3-4):199-205. PubMed ID: 6817641
    [No Abstract]   [Full Text] [Related]  

  • 6. Massive proteinuria in light chain disease.
    Hayes JS; Jankey N; Cuthbert AL; Das PM
    Arch Intern Med; 1978 May; 138(5):785-6. PubMed ID: 417687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary monoclonal gammopathy after bone marrow autotransplantation as a cause of worse renal function in light chain immunoglobulin deposition disease].
    Rekhtina IG; Mendeleeva LP; Stolyarevich ES; Galtseva IV; Povilaitite PE; Biryukova LS
    Ter Arkh; 2016; 88(6):80-83. PubMed ID: 27296267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications.
    Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC
    Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal immunoglobulin deposition disease associated with membranous features.
    Komatsuda A; Masai R; Ohtani H; Togashi M; Maki N; Sawada K; Wakui H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition disease.
    Bender S; Ayala MV; Bonaud A; Javaugue V; Carrion C; Oblet C; Rinsant A; Kaaki S; Oruc Z; Boyer F; Paquet A; Pons N; Hervé B; Ashi MO; Jaccard A; Delpy L; Touchard G; Cogné M; Bridoux F; Sirac C
    Blood; 2020 Oct; 136(14):1645-1656. PubMed ID: 32559766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal neuropathy with monoclonal IgG kappa that binds to a neurofilament protein.
    Nemni R; Feltri ML; Fazio R; Quattrini A; Lorenzetti I; Corbo M; Canal N
    Ann Neurol; 1990 Sep; 28(3):361-4. PubMed ID: 2122795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic renal failure due to light chain deposition disease].
    García Pérez A; Aneiros J; Ramos AM; Petkov V; López Lorenzo JL; Albalate M; Caramelo C; Miguel MT; Barat A
    Nefrologia; 2008; 28(2):212-5. PubMed ID: 18454713
    [No Abstract]   [Full Text] [Related]  

  • 13. [A "pulseless" woman with proteinuria!].
    Garcia C; Renard C; Delacour H; El Jahiri Y; Merens A; Berets O; Vest P
    Ann Biol Clin (Paris); 2004; 62(4):441-5. PubMed ID: 15297239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
    Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
    Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab?
    Kuypers DR; Lerut E; Claes K; Evenepoel P; Vanrenterghem Y
    Transpl Int; 2007 Apr; 20(4):381-5. PubMed ID: 17326779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of light-chain deposition disease after renal transplantation.
    Larsen T; Hammer A; Jørgensen KA
    Scand J Urol Nephrol; 2008; 42(2):187-8. PubMed ID: 17853051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
    Diamantidis MD; Ioannidou-Papagiannaki E; Ntaios G
    Clin Biochem; 2009 Jul; 42(10-11):1202-3. PubMed ID: 19375413
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
    Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
    Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Now you see it, now you don't: A case of covert (invisible) IgM.
    Tsui AKY; Curran M; Rowe P; Savoy M; Higgins T
    Clin Biochem; 2018 Jan; 51():101-102. PubMed ID: 28655558
    [No Abstract]   [Full Text] [Related]  

  • 20. Quiz page March 2009: A 58-year-old man with chronic hepatitis B, nephrotic syndrome, and a papulosquamous rash.
    Hoefsloot W; Reichert L; Meijer J; Richter C
    Am J Kidney Dis; 2009 Mar; 53(3):xxxv-xxxvii. PubMed ID: 19231733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.